Market Tracker

07/25 6:05pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

14.59
Data as of Jul 25
 -0.1599 / -1.08%
Today’s Change
9.01
Today|||52-Week Range
21.00
+23.64%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close14.75
Today’s open15.02
Day’s range14.44 - 15.02
Volume1,394
Average volume (3 months)8,295
Market cap$129.5M
Dividend yield--
Data as of 3:28pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)+14.73%
Earnings growth (this year)+34.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.76%
P/E ratio--
Price/Sales6,117.05
Price/Book10.81

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc-0.01-0.59%
ARGSArgos Therapeutics I...-0.08-1.22%
CNATConatus Pharmaceutic...-0.20-2.49%
RNNRexahn Pharmaceutica...-0.00-0.24%
Data as of 4:00pm ET, 07/25/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$12.0K
Annual profit (last year)-$10.7M
Net profit margin-88,566.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, --

Forecasts